-
公开(公告)号:US10583301B2
公开(公告)日:2020-03-10
申请号:US15804768
申请日:2017-11-06
Applicant: CARDIAC PACEMAKERS, INC.
Inventor: Benjamin J. Haasl , Michael J. Kane , Arthur J. Foster , Lance Eric Juffer , Michael J. Johnson , Keith R. Maile , Brian L. Schmidt , Brendan Early Koop
Abstract: An implantable medical device (IMD) may be deployed within a patient's right atrium at a location near a right atrial appendage of the patient's heart in order to pace the patient's heart and/or to sense electrical activity within the patient's heart. In some cases, an IMD may be implanted within the right atrial appendage. The IMD may include an expandable anchoring mechanism configured to secure the IMD in place.
-
公开(公告)号:US10556119B2
公开(公告)日:2020-02-11
申请号:US15668949
申请日:2017-08-04
Applicant: Cardiac Pacemakers, Inc.
Inventor: John M. Edgell , Keith R. Maile , William J. Linder , Arthur J. Foster , Bryan J. Swackhamer , Michael J. Kane , John Reardon
Abstract: An implantable pulse generator includes a device housing containing pulse generator circuitry and a header connected to the device housing. The header includes a core assembly defining first and second lead bore cavities sized for receiving terminal pins of leads, first and second labels, and an outer layer. The first label is printed onto a surface of the core assembly proximate the first lead bore cavity and includes a first color. The second label is printed onto the surface of the core assembly proximate the second lead bore cavity and includes a second color different from the first color. The outer layer is overmolded over the core assembly so as to encapsulate the first and second labels and to allow access to the first and second lead bore cavities.
-
公开(公告)号:US20200001092A1
公开(公告)日:2020-01-02
申请号:US16535890
申请日:2019-08-08
Applicant: CARDIAC PACEMAKERS, INC.
Inventor: Bin Mi , Pramodsingh Hirasingh Thakur , Jeffrey E. Stahmann , Keith R. Maile , Qi An , Brendan Early Koop , Yinghong Yu , Viktoria A. Averina , Michael J. Kane , Krzysztof Z. Siejko
Abstract: An implantable medical device (IMD) that includes a housing, a first electrode secured relative to the housing, a second electrode secured relative to the housing, and a gyroscope secured relative to the housing. The IMD may include circuitry in the housing in communication with the first electrode, the second electrode, and the gyroscope. The circuitry may be configured to determine and store a plurality of torsion data measurements, from which a representation of a twist profile may be determined.
-
公开(公告)号:US10357159B2
公开(公告)日:2019-07-23
申请号:US15240756
申请日:2016-08-18
Applicant: Cardiac Pacemakers, Inc.
Inventor: Brian L. Schmidt , Lance Eric Juffer , Keith R. Maile , Michael J. Kane , Brendan Early Koop
Abstract: Systems and methods for conducted communication are described. In one embodiment, a method for communicating with implantable medical devices may comprise sensing, by a first medical device, a noise signal delivered into a patient's body by a second medical device and delivering, by the first medical device, a cancelling signal into the patient's body. In at least some additional embodiments the method may further comprise, while delivering the cancelling signal into the patient's body, delivering a conducted communication signal into the patient's body for reception by a second medical device.
-
25.
公开(公告)号:US20190201701A1
公开(公告)日:2019-07-04
申请号:US16239171
申请日:2019-01-03
Applicant: CARDIAC PACEMAKERS, INC.
Inventor: Ron A. Balczewski , William J. Linder , Keith R. Maile
CPC classification number: A61N1/37223 , A61N1/36514 , A61N1/36521 , A61N1/37247 , A61N1/3756 , H04M1/72527 , H04W4/80 , H04W84/18
Abstract: A bridge device includes a housing, a plurality of electrodes exposed outside of the housing such that at least two of the plurality of electrodes can be concurrently placed in contact with a patient's skin. A controller is disposed within the housing. A first communications module is operably coupled to the controller and to the at least two of the plurality of electrodes. The first communications module is configured to allow the controller to communicate with an implantable medical device via at least two of the plurality of electrodes using conducted communication. A second communications module is operably coupled to the controller and is configured to allow the controller to communicate with a remote device external to the patient.
-
公开(公告)号:US20190192816A1
公开(公告)日:2019-06-27
申请号:US16291529
申请日:2019-03-04
Applicant: Cardiac Pacemakers, Inc.
Inventor: Brian L. Schmidt , Benjamin J. Haasl , Keith R. Maile , Eric Bielefeld , Dana Sachs , Adwait Kumar , Indaka Gunasekara
CPC classification number: A61M25/0082 , A61M25/0147 , A61N1/056 , A61N1/362 , A61N1/3756
Abstract: Delivery devices, systems, and methods for delivering implantable leadless pacing devices are disclosed. An example delivery device may include a proximal section including a deflection mechanism for deflecting the proximal section, and a distal holding section extending distally of a distal end of the proximal section and defining a cavity therein for receiving an implantable leadless pacing device. The delivery device may include more than one deflection mechanism for deflecting the proximal section at multiple deflection regions. The delivery device may include more than one tubular member that are translatable relative to one another, and the one or more tubular members may include fixed curve portions. The delivery device may include an atraumatic or bumper tip at the distal end of the holding section.
-
公开(公告)号:US20190167112A1
公开(公告)日:2019-06-06
申请号:US16136773
申请日:2018-09-20
Applicant: Cardiac Pacemakers, Inc.
Inventor: Michael J. Kane , Keith R. Maile , Yingbo Li , Jean M. Bobgan
Abstract: Embodiments herein relate to optoelectronic interfaces for multimode analyte sensors for use with implantable medical devices. In an embodiment, an implantable medical device is included. The implantable medical device can include a first chemical sensor including an optical excitation assembly comprising a first visible spectrum emitter, a second visible spectrum emitter, and at least one of a near-infrared (NIR) emitter and an ultraviolet emitter. The first chemical sensor can also include an optical detection assembly including a colorimetric response detector, and a photoluminescent response detector. The first chemical sensor can also include a multimode sensing element including a colorimetric response element specific for a first chemical analyte, a photoluminescent response element specific for a second chemical analyte. Other embodiments are also included herein.
-
公开(公告)号:US20190134412A1
公开(公告)日:2019-05-09
申请号:US16181943
申请日:2018-11-06
Applicant: CARDIAC PACEMAKERS, INC.
Abstract: A leadless cardiac pacemaker (LCP) that is configured for atrial placement may include a housing, two or more electrodes and a controller that is disposed within the housing and that is operably coupled to the two or more electrodes. The controller may be configured to sense activation of the atrium of the patient's heart via two or more of the electrodes and to deliver pacing therapy via two or more of the electrodes to a ventricle of the patient's heart by pacing the bundle of His in the patient's atrioventricular septum.
-
公开(公告)号:US20190083791A1
公开(公告)日:2019-03-21
申请号:US16192420
申请日:2018-11-15
Applicant: Cardiac Pacemakers, Inc.
Inventor: Michael J. Kane , Allan Charles Shuros , Brian L. Schmidt , Keith R. Maile , Benjamin J. Haasl
CPC classification number: A61N1/3704 , A61B5/0031 , A61B5/02028 , A61B5/024 , A61B5/029 , A61B5/11 , A61B5/6869 , A61B2562/0219 , A61N1/057 , A61N1/3756
Abstract: Systems, methods, and devices for determining occurrences of a tamponade condition are disclosed. One exemplary method includes monitoring an accelerometer signal of a leadless cardiac pacemaker attached to a heart wall, determining if a tamponade condition of the patient's heart is indicated based at least in part on the monitored accelerometer signal, and in response to determining that the tamponade condition is indicated, providing a notification of the tamponade condition for use by a physician to take corrective action.
-
公开(公告)号:US10220213B2
公开(公告)日:2019-03-05
申请号:US15015792
申请日:2016-02-04
Applicant: CARDIAC PACEMAKERS, INC.
Inventor: Paul Huelskamp , Jacob M. Ludwig , Lance E. Juffer , Keith R. Maile
Abstract: Systems and methods for treating arrhythmias are disclosed. In one embodiment an LCP comprises a housing, a plurality of electrodes for sensing electrical signals emanating from outside of the housing, an energy storage module disposed within the housing, and a control module disposed within the housing and operatively coupled to the plurality of electrodes. The control module may be configured to receive electrical signals via two or more of the plurality of electrodes and determine if the received electrical signals are indicative of a command for the LCP to deliver ATP therapy. If the received electrical signals are indicative of a command for the LCP to deliver ATP therapy, the control module may additionally determine whether a triggered ATP therapy mode of the LCP is enabled. If the triggered ATP therapy mode is enabled, the control module may cause the LCP to deliver ATP therapy via the plurality of electrodes.
-
-
-
-
-
-
-
-
-